HEADER IMMUNE SYSTEM 23-JUN-22 8A8M TITLE STRUCTURE OF THE MAPK P38ALPHA IN COMPLEX WITH ITS ACTIVATING MAP2K TITLE 2 MKK6 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE 14,MAPK 14,CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY COMPND 5 DRUG-BINDING PROTEIN,CSAID-BINDING PROTEIN,CSBP,MAP KINASE MXI2,MAX- COMPND 6 INTERACTING PROTEIN 2,MITOGEN-ACTIVATED PROTEIN KINASE P38 ALPHA,MAP COMPND 7 KINASE P38 ALPHA,STRESS-ACTIVATED PROTEIN KINASE 2A,SAPK2A; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6; COMPND 13 CHAIN: B; COMPND 14 SYNONYM: MAP KINASE KINASE 6,MAPKK 6,MAPK/ERK KINASE 6,MEK 6,STRESS- COMPND 15 ACTIVATED PROTEIN KINASE KINASE 3,SAPK KINASE 3,SAPKK-3,SAPKK3; COMPND 16 EC: 2.7.12.2; COMPND 17 ENGINEERED: YES; COMPND 18 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PET; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-28B+; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: MAP2K6, MEK6, MKK6, PRKMK6, SKK3; SOURCE 16 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS KINASE, SIGNALLING, MAP KINASE, PHOSPHORYL TRANSFER, IMMUNE SYSTEM EXPDTA ELECTRON MICROSCOPY AUTHOR M.W.BOWLER,P.JUYOUX,E.PELLEGRINI REVDAT 4 27-SEP-23 8A8M 1 JRNL REMARK REVDAT 3 20-SEP-23 8A8M 1 JRNL REVDAT 2 03-AUG-22 8A8M 1 JRNL REVDAT 1 13-JUL-22 8A8M 0 JRNL AUTH P.JUYOUX,I.GALDADAS,D.GOBBO,J.VON VELSEN,M.PELOSSE,M.TULLY, JRNL AUTH 2 O.VADAS,F.L.GERVASIO,E.PELLEGRINI,M.W.BOWLER JRNL TITL ARCHITECTURE OF THE MKK6-P38 ALPHA COMPLEX DEFINES THE BASIS JRNL TITL 2 OF MAPK SPECIFICITY AND ACTIVATION. JRNL REF SCIENCE V. 381 1217 2023 JRNL REFN ESSN 1095-9203 JRNL PMID 37708276 JRNL DOI 10.1126/SCIENCE.ADD7859 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.JUYOUX,I.GALDADAS,D.GOBBO,M.TULLY,F.L.GERVASIO, REMARK 1 AUTH 2 E.PELLEGRINI,M.W.BOWLER REMARK 1 TITL ARCHITECTURE OF THE MKK6-P38 ALPHA COMPLEX DEFINES THE BASIS REMARK 1 TITL 2 OF MAPK SPECIFICITY AND ACTIVATION REMARK 1 REF BIORXIV 2022 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2022.07.04.498667 REMARK 2 REMARK 2 RESOLUTION. 4.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, SERIALEM, CRYOSPARC, PHENIX, REMARK 3 CRYOSPARC, CRYOSPARC, CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 5ETC REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : RIGID BODY FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.000 REMARK 3 NUMBER OF PARTICLES : 35123 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8A8M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1292123856. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : COMPLEX BETWEEN THE MAP2K MKK6 REMARK 245 AND ITS SUBSTRATE MAPK P38ALPHA; REMARK 245 MITOGEN-ACTIVATED PROTEIN REMARK 245 KINASE 14 (MAPK P38ALPHA); DUAL REMARK 245 SPECIFICITY MITOGEN-ACTIVATED REMARK 245 PROTEIN KINASE KINASE 6 (MAP2K REMARK 245 MKK6) REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.48 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : BLOT FOR 3.5 SECONDS REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 28633 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 QUANTUM (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6277.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : 215000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -66.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -20 REMARK 465 GLY A -19 REMARK 465 SER A -18 REMARK 465 SER A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 SER A -10 REMARK 465 SER A -9 REMARK 465 GLY A -8 REMARK 465 LEU A -7 REMARK 465 GLU A -6 REMARK 465 VAL A -5 REMARK 465 LEU A -4 REMARK 465 PHE A -3 REMARK 465 GLN A -2 REMARK 465 GLY A -1 REMARK 465 PRO A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 GLU A 4 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 465 MET B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 GLN B 0 REMARK 465 ILE B 15 REMARK 465 PRO B 16 REMARK 465 LYS B 17 REMARK 465 GLU B 18 REMARK 465 ALA B 19 REMARK 465 PHE B 20 REMARK 465 GLU B 21 REMARK 465 GLN B 22 REMARK 465 PRO B 23 REMARK 465 GLN B 24 REMARK 465 THR B 25 REMARK 465 SER B 26 REMARK 465 SER B 27 REMARK 465 THR B 28 REMARK 465 PRO B 29 REMARK 465 PRO B 30 REMARK 465 ARG B 31 REMARK 465 ASP B 32 REMARK 465 LEU B 33 REMARK 465 ASP B 34 REMARK 465 SER B 35 REMARK 465 LYS B 36 REMARK 465 ALA B 37 REMARK 465 VAL B 205 REMARK 465 ASP B 206 REMARK 465 ASP B 207 REMARK 465 VAL B 208 REMARK 465 ALA B 209 REMARK 465 LYS B 210 REMARK 465 ASP B 211 REMARK 465 ILE B 212 REMARK 465 ASP B 213 REMARK 465 ALA B 214 REMARK 465 GLY B 215 REMARK 465 CYS B 216 REMARK 465 LYS B 217 REMARK 465 LEU B 335 REMARK 465 GLU B 336 REMARK 465 VAL B 337 REMARK 465 LEU B 338 REMARK 465 PHE B 339 REMARK 465 GLN B 340 REMARK 465 GLY B 341 REMARK 465 PRO B 342 REMARK 465 TRP B 343 REMARK 465 SER B 344 REMARK 465 HIS B 345 REMARK 465 PRO B 346 REMARK 465 GLN B 347 REMARK 465 PHE B 348 REMARK 465 GLU B 349 REMARK 465 LYS B 350 REMARK 465 GLY B 351 REMARK 465 GLY B 352 REMARK 465 GLY B 353 REMARK 465 SER B 354 REMARK 465 GLY B 355 REMARK 465 GLY B 356 REMARK 465 GLY B 357 REMARK 465 SER B 358 REMARK 465 GLY B 359 REMARK 465 GLY B 360 REMARK 465 SER B 361 REMARK 465 ALA B 362 REMARK 465 TRP B 363 REMARK 465 SER B 364 REMARK 465 HIS B 365 REMARK 465 PRO B 366 REMARK 465 GLN B 367 REMARK 465 PHE B 368 REMARK 465 GLU B 369 REMARK 465 LYS B 370 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 34 -64.83 -29.58 REMARK 500 LYS A 76 33.01 -97.46 REMARK 500 HIS A 77 -35.06 -142.93 REMARK 500 ALA A 111 -168.33 -123.23 REMARK 500 ARG A 149 -2.06 64.86 REMARK 500 PRO A 153 2.37 -57.63 REMARK 500 CYS A 162 16.32 58.62 REMARK 500 TYR A 182 -156.97 56.52 REMARK 500 TYR A 188 -156.18 -148.44 REMARK 500 ARG A 189 -5.20 85.51 REMARK 500 ALA A 190 160.77 63.14 REMARK 500 GLN A 202 -5.72 -59.21 REMARK 500 LEU A 238 -62.51 -96.94 REMARK 500 PRO A 266 -177.15 -68.16 REMARK 500 PRO A 352 -178.57 -69.72 REMARK 500 THR B 149 -168.39 55.52 REMARK 500 ARG B 178 -2.84 67.87 REMARK 500 TYR B 257 54.32 -91.39 REMARK 500 LYS B 282 2.73 59.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 902 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 168 OD2 REMARK 620 2 AP2 A 900 O1B 95.9 REMARK 620 3 AP2 A 900 O3B 115.3 56.9 REMARK 620 N 1 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-15233 RELATED DB: EMDB REMARK 900 STRUCTURE OF THE MAPK P38ALPHA IN COMPLEX WITH ITS ACTIVATING MAP2K REMARK 900 MKK6 DBREF 8A8M A 1 360 UNP Q16539 MK14_HUMAN 1 360 DBREF 8A8M B 15 334 UNP P52564 MP2K6_HUMAN 15 334 SEQADV 8A8M MET A -20 UNP Q16539 INITIATING METHIONINE SEQADV 8A8M GLY A -19 UNP Q16539 EXPRESSION TAG SEQADV 8A8M SER A -18 UNP Q16539 EXPRESSION TAG SEQADV 8A8M SER A -17 UNP Q16539 EXPRESSION TAG SEQADV 8A8M HIS A -16 UNP Q16539 EXPRESSION TAG SEQADV 8A8M HIS A -15 UNP Q16539 EXPRESSION TAG SEQADV 8A8M HIS A -14 UNP Q16539 EXPRESSION TAG SEQADV 8A8M HIS A -13 UNP Q16539 EXPRESSION TAG SEQADV 8A8M HIS A -12 UNP Q16539 EXPRESSION TAG SEQADV 8A8M HIS A -11 UNP Q16539 EXPRESSION TAG SEQADV 8A8M SER A -10 UNP Q16539 EXPRESSION TAG SEQADV 8A8M SER A -9 UNP Q16539 EXPRESSION TAG SEQADV 8A8M GLY A -8 UNP Q16539 EXPRESSION TAG SEQADV 8A8M LEU A -7 UNP Q16539 EXPRESSION TAG SEQADV 8A8M GLU A -6 UNP Q16539 EXPRESSION TAG SEQADV 8A8M VAL A -5 UNP Q16539 EXPRESSION TAG SEQADV 8A8M LEU A -4 UNP Q16539 EXPRESSION TAG SEQADV 8A8M PHE A -3 UNP Q16539 EXPRESSION TAG SEQADV 8A8M GLN A -2 UNP Q16539 EXPRESSION TAG SEQADV 8A8M GLY A -1 UNP Q16539 EXPRESSION TAG SEQADV 8A8M PRO A 0 UNP Q16539 EXPRESSION TAG SEQADV 8A8M VAL A 180 UNP Q16539 THR 180 ENGINEERED MUTATION SEQADV 8A8M MET B -3 UNP P52564 INITIATING METHIONINE SEQADV 8A8M GLY B -2 UNP P52564 EXPRESSION TAG SEQADV 8A8M SER B -1 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLN B 0 UNP P52564 EXPRESSION TAG SEQADV 8A8M LEU B 1 UNP P52564 EXPRESSION TAG SEQADV 8A8M LEU B 2 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLU B 3 UNP P52564 EXPRESSION TAG SEQADV 8A8M ARG B 4 UNP P52564 EXPRESSION TAG SEQADV 8A8M ARG B 5 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLY B 6 UNP P52564 EXPRESSION TAG SEQADV 8A8M VAL B 7 UNP P52564 EXPRESSION TAG SEQADV 8A8M SER B 8 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLU B 9 UNP P52564 EXPRESSION TAG SEQADV 8A8M LEU B 10 UNP P52564 EXPRESSION TAG SEQADV 8A8M PRO B 11 UNP P52564 EXPRESSION TAG SEQADV 8A8M PRO B 12 UNP P52564 EXPRESSION TAG SEQADV 8A8M LEU B 13 UNP P52564 EXPRESSION TAG SEQADV 8A8M TYR B 14 UNP P52564 EXPRESSION TAG SEQADV 8A8M ASP B 207 UNP P52564 SER 207 ENGINEERED MUTATION SEQADV 8A8M ASP B 211 UNP P52564 THR 211 ENGINEERED MUTATION SEQADV 8A8M LEU B 335 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLU B 336 UNP P52564 EXPRESSION TAG SEQADV 8A8M VAL B 337 UNP P52564 EXPRESSION TAG SEQADV 8A8M LEU B 338 UNP P52564 EXPRESSION TAG SEQADV 8A8M PHE B 339 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLN B 340 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLY B 341 UNP P52564 EXPRESSION TAG SEQADV 8A8M PRO B 342 UNP P52564 EXPRESSION TAG SEQADV 8A8M TRP B 343 UNP P52564 EXPRESSION TAG SEQADV 8A8M SER B 344 UNP P52564 EXPRESSION TAG SEQADV 8A8M HIS B 345 UNP P52564 EXPRESSION TAG SEQADV 8A8M PRO B 346 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLN B 347 UNP P52564 EXPRESSION TAG SEQADV 8A8M PHE B 348 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLU B 349 UNP P52564 EXPRESSION TAG SEQADV 8A8M LYS B 350 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLY B 351 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLY B 352 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLY B 353 UNP P52564 EXPRESSION TAG SEQADV 8A8M SER B 354 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLY B 355 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLY B 356 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLY B 357 UNP P52564 EXPRESSION TAG SEQADV 8A8M SER B 358 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLY B 359 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLY B 360 UNP P52564 EXPRESSION TAG SEQADV 8A8M SER B 361 UNP P52564 EXPRESSION TAG SEQADV 8A8M ALA B 362 UNP P52564 EXPRESSION TAG SEQADV 8A8M TRP B 363 UNP P52564 EXPRESSION TAG SEQADV 8A8M SER B 364 UNP P52564 EXPRESSION TAG SEQADV 8A8M HIS B 365 UNP P52564 EXPRESSION TAG SEQADV 8A8M PRO B 366 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLN B 367 UNP P52564 EXPRESSION TAG SEQADV 8A8M PHE B 368 UNP P52564 EXPRESSION TAG SEQADV 8A8M GLU B 369 UNP P52564 EXPRESSION TAG SEQADV 8A8M LYS B 370 UNP P52564 EXPRESSION TAG SEQRES 1 A 381 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 381 LEU GLU VAL LEU PHE GLN GLY PRO MET SER GLN GLU ARG SEQRES 3 A 381 PRO THR PHE TYR ARG GLN GLU LEU ASN LYS THR ILE TRP SEQRES 4 A 381 GLU VAL PRO GLU ARG TYR GLN ASN LEU SER PRO VAL GLY SEQRES 5 A 381 SER GLY ALA TYR GLY SER VAL CYS ALA ALA PHE ASP THR SEQRES 6 A 381 LYS THR GLY LEU ARG VAL ALA VAL LYS LYS LEU SER ARG SEQRES 7 A 381 PRO PHE GLN SER ILE ILE HIS ALA LYS ARG THR TYR ARG SEQRES 8 A 381 GLU LEU ARG LEU LEU LYS HIS MET LYS HIS GLU ASN VAL SEQRES 9 A 381 ILE GLY LEU LEU ASP VAL PHE THR PRO ALA ARG SER LEU SEQRES 10 A 381 GLU GLU PHE ASN ASP VAL TYR LEU VAL THR HIS LEU MET SEQRES 11 A 381 GLY ALA ASP LEU ASN ASN ILE VAL LYS CYS GLN LYS LEU SEQRES 12 A 381 THR ASP ASP HIS VAL GLN PHE LEU ILE TYR GLN ILE LEU SEQRES 13 A 381 ARG GLY LEU LYS TYR ILE HIS SER ALA ASP ILE ILE HIS SEQRES 14 A 381 ARG ASP LEU LYS PRO SER ASN LEU ALA VAL ASN GLU ASP SEQRES 15 A 381 CYS GLU LEU LYS ILE LEU ASP PHE GLY LEU ALA ARG HIS SEQRES 16 A 381 THR ASP ASP GLU MET VAL GLY TYR VAL ALA THR ARG TRP SEQRES 17 A 381 TYR ARG ALA PRO GLU ILE MET LEU ASN TRP MET HIS TYR SEQRES 18 A 381 ASN GLN THR VAL ASP ILE TRP SER VAL GLY CYS ILE MET SEQRES 19 A 381 ALA GLU LEU LEU THR GLY ARG THR LEU PHE PRO GLY THR SEQRES 20 A 381 ASP HIS ILE ASP GLN LEU LYS LEU ILE LEU ARG LEU VAL SEQRES 21 A 381 GLY THR PRO GLY ALA GLU LEU LEU LYS LYS ILE SER SER SEQRES 22 A 381 GLU SER ALA ARG ASN TYR ILE GLN SER LEU THR GLN MET SEQRES 23 A 381 PRO LYS MET ASN PHE ALA ASN VAL PHE ILE GLY ALA ASN SEQRES 24 A 381 PRO LEU ALA VAL ASP LEU LEU GLU LYS MET LEU VAL LEU SEQRES 25 A 381 ASP SER ASP LYS ARG ILE THR ALA ALA GLN ALA LEU ALA SEQRES 26 A 381 HIS ALA TYR PHE ALA GLN TYR HIS ASP PRO ASP ASP GLU SEQRES 27 A 381 PRO VAL ALA ASP PRO TYR ASP GLN SER PHE GLU SER ARG SEQRES 28 A 381 ASP LEU LEU ILE ASP GLU TRP LYS SER LEU THR TYR ASP SEQRES 29 A 381 GLU VAL ILE SER PHE VAL PRO PRO PRO LEU ASP GLN GLU SEQRES 30 A 381 GLU MET GLU SER SEQRES 1 B 374 MET GLY SER GLN LEU LEU GLU ARG ARG GLY VAL SER GLU SEQRES 2 B 374 LEU PRO PRO LEU TYR ILE PRO LYS GLU ALA PHE GLU GLN SEQRES 3 B 374 PRO GLN THR SER SER THR PRO PRO ARG ASP LEU ASP SER SEQRES 4 B 374 LYS ALA CYS ILE SER ILE GLY ASN GLN ASN PHE GLU VAL SEQRES 5 B 374 LYS ALA ASP ASP LEU GLU PRO ILE MET GLU LEU GLY ARG SEQRES 6 B 374 GLY ALA TYR GLY VAL VAL GLU LYS MET ARG HIS VAL PRO SEQRES 7 B 374 SER GLY GLN ILE MET ALA VAL LYS ARG ILE ARG ALA THR SEQRES 8 B 374 VAL ASN SER GLN GLU GLN LYS ARG LEU LEU MET ASP LEU SEQRES 9 B 374 ASP ILE SER MET ARG THR VAL ASP CYS PRO PHE THR VAL SEQRES 10 B 374 THR PHE TYR GLY ALA LEU PHE ARG GLU GLY ASP VAL TRP SEQRES 11 B 374 ILE CYS MET GLU LEU MET ASP THR SER LEU ASP LYS PHE SEQRES 12 B 374 TYR LYS GLN VAL ILE ASP LYS GLY GLN THR ILE PRO GLU SEQRES 13 B 374 ASP ILE LEU GLY LYS ILE ALA VAL SER ILE VAL LYS ALA SEQRES 14 B 374 LEU GLU HIS LEU HIS SER LYS LEU SER VAL ILE HIS ARG SEQRES 15 B 374 ASP VAL LYS PRO SER ASN VAL LEU ILE ASN ALA LEU GLY SEQRES 16 B 374 GLN VAL LYS MET CYS ASP PHE GLY ILE SER GLY TYR LEU SEQRES 17 B 374 VAL ASP ASP VAL ALA LYS ASP ILE ASP ALA GLY CYS LYS SEQRES 18 B 374 PRO TYR MET ALA PRO GLU ARG ILE ASN PRO GLU LEU ASN SEQRES 19 B 374 GLN LYS GLY TYR SER VAL LYS SER ASP ILE TRP SER LEU SEQRES 20 B 374 GLY ILE THR MET ILE GLU LEU ALA ILE LEU ARG PHE PRO SEQRES 21 B 374 TYR ASP SER TRP GLY THR PRO PHE GLN GLN LEU LYS GLN SEQRES 22 B 374 VAL VAL GLU GLU PRO SER PRO GLN LEU PRO ALA ASP LYS SEQRES 23 B 374 PHE SER ALA GLU PHE VAL ASP PHE THR SER GLN CYS LEU SEQRES 24 B 374 LYS LYS ASN SER LYS GLU ARG PRO THR TYR PRO GLU LEU SEQRES 25 B 374 MET GLN HIS PRO PHE PHE THR LEU HIS GLU SER LYS GLY SEQRES 26 B 374 THR ASP VAL ALA SER PHE VAL LYS LEU ILE LEU GLY ASP SEQRES 27 B 374 LEU GLU VAL LEU PHE GLN GLY PRO TRP SER HIS PRO GLN SEQRES 28 B 374 PHE GLU LYS GLY GLY GLY SER GLY GLY GLY SER GLY GLY SEQRES 29 B 374 SER ALA TRP SER HIS PRO GLN PHE GLU LYS HET AP2 A 900 27 HET MG A 901 1 HET MG A 902 1 HET AP2 B 401 27 HET MG B 402 1 HET MG B 403 1 HETNAM AP2 PHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER HETNAM MG MAGNESIUM ION FORMUL 3 AP2 2(C11 H17 N5 O9 P2) FORMUL 4 MG 4(MG 2+) HELIX 1 AA1 ILE A 62 LYS A 76 1 15 HELIX 2 AA2 LEU A 113 GLN A 120 1 8 HELIX 3 AA3 THR A 123 ASP A 145 1 23 HELIX 4 AA4 ARG A 189 LEU A 195 1 7 HELIX 5 AA5 ASN A 201 THR A 218 1 18 HELIX 6 AA6 ILE A 229 GLY A 240 1 12 HELIX 7 AA7 SER A 252 ASN A 257 1 6 HELIX 8 AA8 ASN A 278 LEU A 289 1 12 HELIX 9 AA9 THR A 298 LEU A 303 1 6 HELIX 10 AB1 ALA A 304 TYR A 311 5 8 HELIX 11 AB2 ASP A 313 GLU A 317 5 5 HELIX 12 AB3 SER A 326 ARG A 330 5 5 HELIX 13 AB4 LEU A 333 ILE A 346 1 14 HELIX 14 AB5 LYS B 49 ASP B 51 5 3 HELIX 15 AB6 ASN B 89 THR B 106 1 18 HELIX 16 AB7 LEU B 136 GLY B 147 1 12 HELIX 17 AB8 PRO B 151 LEU B 173 1 23 HELIX 18 AB9 LYS B 181 SER B 183 5 3 HELIX 19 AC1 ALA B 221 ASN B 226 1 6 HELIX 20 AC2 SER B 235 LEU B 253 1 19 HELIX 21 AC3 THR B 262 GLU B 273 1 12 HELIX 22 AC4 SER B 284 LEU B 295 1 12 HELIX 23 AC5 THR B 304 HIS B 311 1 8 HELIX 24 AC6 HIS B 311 LYS B 320 1 10 HELIX 25 AC7 ASP B 323 GLY B 333 1 11 SHEET 1 AA1 2 TYR A 9 LEU A 13 0 SHEET 2 AA1 2 THR A 16 VAL A 20 -1 O TRP A 18 N GLN A 11 SHEET 1 AA2 2 TYR A 24 LEU A 27 0 SHEET 2 AA2 2 ALA A 41 ASP A 43 -1 O PHE A 42 N GLN A 25 SHEET 1 AA3 2 ALA A 51 LYS A 53 0 SHEET 2 AA3 2 LEU A 104 THR A 106 -1 O THR A 106 N ALA A 51 SHEET 1 AA4 3 ALA A 111 ASP A 112 0 SHEET 2 AA4 3 LEU A 156 VAL A 158 -1 O VAL A 158 N ALA A 111 SHEET 3 AA4 3 LYS A 165 ILE A 166 -1 O LYS A 165 N ALA A 157 SHEET 1 AA5 2 ILE B 39 ILE B 41 0 SHEET 2 AA5 2 GLN B 44 PHE B 46 -1 O PHE B 46 N ILE B 39 SHEET 1 AA6 4 LEU B 53 GLU B 58 0 SHEET 2 AA6 4 GLU B 68 HIS B 72 -1 O ARG B 71 N GLU B 54 SHEET 3 AA6 4 ILE B 78 ALA B 80 -1 O MET B 79 N MET B 70 SHEET 4 AA6 4 MET B 129 GLU B 130 -1 O MET B 129 N ALA B 80 SHEET 1 AA7 3 THR B 134 SER B 135 0 SHEET 2 AA7 3 VAL B 185 ILE B 187 -1 O ILE B 187 N THR B 134 SHEET 3 AA7 3 VAL B 193 MET B 195 -1 O LYS B 194 N LEU B 186 SHEET 1 AA8 2 VAL B 175 ILE B 176 0 SHEET 2 AA8 2 GLY B 202 TYR B 203 -1 O GLY B 202 N ILE B 176 LINK OD2 ASP A 168 MG MG A 902 1555 1555 2.78 LINK O1B AP2 A 900 MG MG A 902 1555 1555 2.65 LINK O3B AP2 A 900 MG MG A 902 1555 1555 2.75 LINK OD1 ASP B 197 MG MG B 402 1555 1555 2.91 LINK O2A AP2 B 401 MG MG B 403 1555 1555 2.69 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000